H.I.G. Capital Selects SEI for Fund Administration and Depositary Services
Global Strategic Partnership to Enable Operational Efficiency, Reduce Replication LUXEMBOURG and DUBLIN, Oct. 8, 2025 /PRNewswire/ — SEI® (NASDAQ:SEIC) today announced that the company was selected by H.I.G. Capital (H.I.G.), a leading global alternative investments firm with $70 billion of capital under management, to provide fund administration and depositary services for certain Luxembourg and Cayman […]
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform
Under the new entitlement agreement, Hoth Therapeutics secures annual NVIDIA AI Enterprise Essentials licenses to support its GPU-powered infrastructure, enabling advanced machine learning and neural network modeling capabilities for pharmaceutical research NEW YORK, Oct. 8, 2025 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for dermatological, oncological […]
Boston Trust Walden Announces Changes to Institutional Portfolio Management Teams
BOSTON, Oct. 8, 2025 /PRNewswire/ — Boston Trust Walden Company today announced several upcoming changes to its institutional portfolio management teams, effective December 31, 2025. Kenneth Scott will step down from his role as portfolio manager of the Small and SMID Cap Equity strategies. Mr. Scott will continue to serve as Co-Chief Executive Officer. Mr. […]
NextPlat Issues CEO Shareholder Update Letter
Company Secures New Healthcare Contracts, Implements Additional Cost Reductions and Launches New AI Powered Proprietary Healthcare Management Software and Consumer Health Products HALLANDALE BEACH, Fla., Oct. 8, 2025 /PRNewswire/ — NextPlat Corp (NASDAQ: NXPL) (NASDAQ: NXPLW) (“NextPlat” or the “Company”), a global consumer products and services company providing healthcare and technology solutions through e-commerce and […]
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode acquires 100% of the issued and outstanding interests of Polynoma from CK Life Sciences Concurrent equity investment of $25 Million from CK Life Sciences into TransCode TransCode expands its microRNA-based pipeline with Polynoma’s Phase 3-ready seviprotimut-L, a novel polyvalent shed antigen vaccine for the adjuvant treatment of melanoma Philippe Calais, PharmD, PhD, becomes Chief […]
Salt Security Report Shows API Security Blind Spots Could Put AI Agent Deployments at Risk
Insecure APIs Threaten the Resilience and Security of AI Projects PALO ALTO, Calif., Oct. 8, 2025 /PRNewswire/ — Salt Security has today released its semi-annual State of API Security Report that exposes an alarming disconnect between rapid API adoption and immature security practices, which threatens the success of critical AI and automation initiatives. The H2 […]
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company’s progress to expand minimally invasive treatment options to patients in the United States GALWAY, Ireland, Oct. 8, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to evaluate the safety and effectiveness of […]
GameAbove Celebrates Record Impact at Eastern Michigan University During 2024-25 Academic Year
Unprecedented philanthropy powers historic athletic wins, cutting-edge research, and big community initiatives YPSILANTI, Mich., Oct. 8, 2025 /PRNewswire/ — GameAbove is celebrating a landmark 2024–25 academic year at Eastern Michigan University (EMU), where its philanthropic investments fueled breakthroughs in athletics, research, student development, and community engagement. From championship-level performances to innovations with global potential, GameAbove’s commitment […]
LIVE NATION ENTERTAINMENT ANNOUNCES LAUNCH OF CONVERTIBLE SENIOR NOTES OFFERING
LOS ANGELES, Oct. 8, 2025 /PRNewswire/ — Live Nation Entertainment, Inc. (NYSE: LYV) (the “company”) today announced that it intends to offer, subject to market and other conditions, $1.3 billion in aggregate principal amount of convertible senior notes due 2031 (the “Convertible Notes”). The company intends to use the net proceeds from the Convertible Notes […]
Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
– Transactions Provide Karyopharm with $100 Million of Financial Flexibility and Additional Capital – – Preliminary Total Revenue and U.S. XPOVIO® (selinexor) Net Product Revenue for the Third Quarter of 2025 Expected to be in the Range of $42 to $44 Million and Approximately $32 Million, Respectively – – Top-Line Data from the Phase 3 SENTRY Trial […]